USPTO serial 78183834
Serial No. 78183834
Reviewed by CopyMark Law Group
Reg. 2946656Status 710
- Filing date
- Status date
- Registration date
- May 3, 2005
- Examiner
- FAIRBANKS, RONALD L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 78183834?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Shenzhen Neptunus Pharmaceutical Co., Ltd.
Shenzhen, CN
Other trademarks owned by Shenzhen Neptunus Pharmaceutical Co., Ltd.
Shenzhen Neptunus Pharmaceutical Co., Ltd.
Shenzhen, CN
Other trademarks owned by Shenzhen Neptunus Pharmaceutical Co., Ltd.
Shenzhen Neptunus Pharmaceutical Co., Ltd.
Shenzhen, CN
Other trademarks owned by Shenzhen Neptunus Pharmaceutical Co., Ltd.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes, namely, antipyretics, analgesics, drugs for osteoporosis, antibiotic drugs, antifungal drugs, drugs for parasitism, antimicrobial drugs, medicines for the treatment of cancers, cardiovascular diseases, diseases of respiratory system, diseases of digestive system, diseases of nervous system, diseases of urinary system, diseases of blood and haemopoietic system, diseases of endocrine system, diseases of immune system; Chemical preparations, namely, antipyretics, analgesics, drugs for osteoporosis, antibiotic drugs, antifungal drugs, drugs for parasitism, antimicrobial drugs, medicines for the treatment of cancers, cardiovascular diseases, diseases of respiratory system, diseases of digestive system, diseases of nervous system, diseases of urinary system, diseases of blood and haemopoietic system, diseases of endocrine system, diseases of immune system; Medicinal herbs; Pharmaceutical preparations, namely, antipyretics, analgesics, drugs for osteoporosis, antibiotic drugs, antifungal drugs, drugs for parasitism, antimicrobial drugs, medicines for the treatment of cancers, cardiovascular diseases, diseases of respiratory system, diseases of digestive system, diseases of nervous system, diseases of urinary system, diseases of blood and haemopoietic system, diseases of endocrine system, diseases of immune system; Biological preparations for pharmaceutical purposes; Dietetic foods adapted for medical purposes; Dietetic beverages adapted for medical purposes; Pills for pharmaceutical purposes, namely, antipyretics, analgesics, drugs for osteoporosis, antibiotic drugs, antifungal drugs, drugs for parasitism, antimicrobial drugs, medicines for the treatment of cancers, cardiovascular diseases, diseases of respiratory system, diseases of digestive system, diseases of nervous system, diseases of urinary system, diseases of blood and haemopoietic system, diseases of endocrine system, diseases of immune system; Bacterial preparations for medical and veterinary use; Veterinary preparations, namely, antipyretics, analgesics, drugs for osteoporosis, antibiotic drugs, antifungal drugs, drugs for parasitism, antimicrobial drugs, medicines for the treatment of cancers, cardiovascular diseases, diseases of respiratory system, diseases of digestive system, diseases of nervous system, diseases of urinary system, diseases of blood and haemopoietic system, diseases of endocrine system, diseases of immune system; Medicines for veterinary purposes, namely, antipyretics, analgesics, drugs for osteoporosis, antibiotic drugs, antifungal drugs, drugs for parasitism, antimicrobial drugs, medicines for the treatment of cancers, cardiovascular diseases, diseases of respiratory system, diseases of digestive system, diseases of nervous system, diseases of urinary system, diseases of blood and haemopoietic system, diseases of endocrine system, diseases of immune system; Sterilizing preparations | SECTION 8 - CANCELLED | Jun 18, 2004 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Shenzhen Neptunus Pharmaceutical Co., Ltd.
- Other trademarks owned by Shenzhen Neptunus Pharmaceutical Co., Ltd.
- Other trademarks owned by Shenzhen Neptunus Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 9, 2011 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 24, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 24, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 3, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 11, 2005 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Feb 11, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jan 24, 2005 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 21, 2004 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 14, 2004 | IUAF | USE AMENDMENT FILED | — |
| Dec 14, 2004 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 22, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 30, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 12, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 10, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 5, 2004 | PAPER RECEIVED | — | |
| Jan 7, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 8, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 8, 2003 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 8, 2003 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 11, 2003 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2003 | DOCK | ASSIGNED TO EXAMINER | — |